Covestor’s Kestra Medical Technologies KMTS Stock Holding History

Covestor’s Portfolio KMTS Stock Details KMTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Buy	20 +14	+233%	+$293	﹤0.01%	2427
2026 Q1	$0	Buy	+6	New	+$141	﹤0.01%	2888

Other funds holding KMTS

BCI

Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Andera Partners Paris $206M AUM

Yu Fan $108M AUM 137.54% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Covestor's KMTS Position: Q2 2026 in Review

Covestor increased its Kestra Medical Technologies (KMTS) stake by 233% in Q2 2026, buying an estimated $293 and bringing the position to 20 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2427.

Covestor first reported a position in KMTS in Q1 2026 and has held it in 2 quarters since. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

Covestor held 20 shares of Kestra Medical Technologies worth $1K as of Q2 2026.
Covestor bought 14 Kestra Medical Technologies shares in Q2 2026, an estimated $293.
Kestra Medical Technologies made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2427 holding.
Covestor first reported a position in Kestra Medical Technologies in Q1 2026 and has held it in 2 quarters since.
109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.